CYTARABINE
- Strength
- 20 mg/mL
- Form
- Injection, Solution
- Class
- Nucleoside Metabolic Inhibitor
Hospira, Inc.
(daunorubicin and cytarabine) liposome
Listed by Jazz Pharmaceuticals, Inc.
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
| Dosage form | Injection, Powder, Lyophilized, For Suspension |
|---|---|
| Route | Intravenous |
| Drug class | Anthracycline Topoisomerase Inhibitor; Nucleoside Metabolic Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 68727-745 |
| FDA application | NDA209401 |
| RxNorm concept | 1942743 |
| Package sizes listed | 2 |
| Marketed since | August 2017 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Hospira, Inc.
Meitheal Pharmaceuticals Inc.
Sagent Pharmaceuticals
Hospira, Inc.
Gland Pharma Limited
Gland Pharma Limited
Meitheal Pharmaceuticals Inc.
Fresenius Kabi USA, LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.